List of works - Thijo Jeroen Nicolaas Hiltermann

An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

scientific article published on 01 October 2020

Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer

scientific article published on 26 November 2019

Asthma severity and susceptibility to air pollution ⬇️

scientific article published on 01 March 1998

Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer.

scientific article published on 8 June 2016

Desensitisation to circumvent hypersensitivity reactions; treatment with docetaxel still possible

scientific article published on 01 January 2011

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer

scientific article

Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics ⬇️

scientific article published on December 1, 2001

Effects of Photochemical Air Pollution and Allergen Exposure on Upper Respiratory Tract Inflammation in Asthmatics ⬇️

scientific article published on 01 December 1997

Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry

scientific article published on 28 December 2019

Immune microenvironment composition in non-small cell lung cancer and its association with survival

scientific article published on 12 June 2020

New 'targeted therapy' for lung cancer

scientific article published on January 1, 2011

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

scientific article published on 30 August 2017

Ozone-Induced Airway Hyperresponsiveness in Patients With Asthma: Role of Neutrophil-Derived Serine Proteinases ⬇️

scientific article published on April 1, 1998

Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature